
Encompass Health
(NYSE) EHC
Encompass Health Financials at a Glance
Market Cap
$10.50B
Revenue (TTM)
$6.07B
Net Income (TTM)
$609.20M
EPS (TTM)
$5.99
P/E Ratio
17.67
Dividend
$0.74
Beta (Volatility)
0.61 (Low)
Dividend
$0.74
Beta (Volatility)
0.61 (Low)
Price
$106.00
Volume
27,943
Open
$104.30
Price
$106.00
Volume
27,943
Open
$104.30
Previous Close
$106.00
Daily Range
$104.30 - $106.90
52-Week Range
$92.77 - $127.99
Dividend
$0.74
Beta (Volatility)
0.61 (Low)
Price
$106.00
Volume
27,943
Open
$104.30
Previous Close
$106.00
Daily Range
$104.30 - $106.90
52-Week Range
$92.77 - $127.99
EHC News
EHC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Encompass Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
42,300
CEO
Mark J. Tarr, MBA
Website
www.encompasshealth.comHeadquarters
Birmingham, AL 35242, US
EHC Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
18%
Net Income Margin
10%
Return on Equity
25%
Return on Capital
17%
Return on Assets
8%
Earnings Yield
5.66%
Dividend Yield
0.70%
Payout Ratio
12.05%
Stock Overview
Market Cap
$10.50B
Shares Outstanding
99.20M
Volume
27.94K
Avg. Volume
940.55K
Financials (TTM)
Gross Profit
$5.68B
Operating Income
$1.05B
EBITDA
$1.40B
Operating Cash Flow
$1.18B
Capital Expenditure
-$736.40M
Free Cash Flow
$439.20M
Cash & ST Invst.
$145.10M
Total Debt
$2.71B
Encompass Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.59B
+9.0%
Gross Profit
$768.50M
+21.8%
Gross Margin
48.44%
N/A
Market Cap
$10.50B
N/A
Market Cap/Employee
$367.50K
N/A
Employees
28,572
N/A
Net Income
$194.50M
+28.4%
EBITDA
$388.90M
+11.2%
Quarterly Fundamentals
Net Cash
-$2.59B
+0.7%
Accounts Receivable
$676.00M
+8.4%
Inventory
$0.00
N/A
Long Term Debt
$2.72B
+7.2%
Short Term Debt
$69.80M
-57.8%
Return on Assets
8.33%
N/A
Return on Invested Capital
16.90%
N/A
Free Cash Flow
$150.70M
+20.1%
Operating Cash Flow
$313.10M
+8.5%




